Novel neuropeptide Y processing in human cerebrospinal fluid from depressed patients

Peptides

Volumn 17, Issue 7, 1996, Pages 1107-1111

  Ekman, Rolf ^a   Juhasz, Peter ^b,c   Heilig, Markus ^a   Ågren, Hans ^a   Costello, Catherine E ^b,d  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c PERKINELMER INC   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

depression; human cerebrospinal fluid; MALDI TOF MS; neuropeptide Y

Indexed keywords

NEUROPEPTIDE Y;

ADULT; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; HUMAN; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN PROCESSING;

ADULT; AMINO ACID SEQUENCE; DEPRESSION; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEUROPEPTIDE Y; PEPTIDE FRAGMENTS;

EID: 0029909866     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(96)00168-4     Document Type: Article

References (25)

1. 1. Ågren, H.; Mefford, N.; Rudorfer, M. V.; Linnoila, M.; Potter, W. Z. Interacting neurotransmitter systems. A nonexperimental approach to the 5 HIAA-HVA correlation in human CSF. J. Psychiatr. Res. 20:175-193; 1986.
2. 2. Beavis R. C.; Chait, B. T. Cinnamic acid derivatives as matrices for ultraviolet laser desorption mass spectrometry of proteins. Rapid Commun. Mass Spectrom. 3:432-435; 1989.
3. 3. Beavis, R. C.; Chaudhary, T.; Chait, B. T. α-Cyano-4-hydroxycin-namic acid as a matrix for matrix-assisted laser desorption mass spectrometry. Org. Mass Spectrom. 27:156-158; 1992.
4. 4. Berrettini, W. H.; Doran, A. R.; Kelsoe, J.; Roy, A.; Pickar, D. Cerebrospinal fluid neuropeptide Y in depression and schizophrenia. Neuropsychopharmacology 1:81-83; 1987.
5. 5. Chou, J. Z.; Kreek, M. J.; Chait, B. T. Matrix-assisted laser desorption mass spectrometry of biotransformation products of dynorphin A in vitro. J. Am. Soc. Mass Spectrom. 5:10-16; 1993.
6. 6. Dawbarn, D.; Hunt, S. P.; Emson, P. C. Neuropeptide Y: Regional distribution, chromatographic characterization and immunohistochemical demonstration in postmortem human brain. Brain Res. 296:168-173; 1984.
7. 7. DeQuill, M. E.; Emson, P. C. Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system - I. Radioimmunoassay and chromatographic characterisation. Neuroscience 18:527-543; 1986.
8. 8. Ekman, R. Radioimmunoassay of neuropeptides in the CSF. Problems and pitfalls. Nord. Psykiatr. Tidskr. 39:31-34; 1985.
9. 9. Giämsta, E.-L.; Nyberg, F.; Silberring, J. Application of fast-atom bombardment mass spectrometry for sequencing of a hemoglobin fragment, naturally occurring in human cerebrospinal fluid. Rapid Commun. Mass Spectrom. 6:777-780; 1992.
10. 10. Grundemar, L.; Sheikh, S. P.; Wahlestedt, C. Characterization of receptor types for neuropeptide Y and related peptides. In: Colmers, W. F.; Wahlestedt, C., eds. The biology of neuropeptide Y. Totowa, NJ: Humana Press; 1993:197-240.
11. 11. Heilig, M.; Koob, G. F.; Ekman, R.; Britton, K. T. Corticotropin-releasing factor and neuropeptide Y: Role in emotional integration. Trends Neurosci. 17:80-85; 1994.
12. 12. Hendry, S. H. C. Organization of NPY neurons in CNS. In: Colmers, W. F.; Wahlestedt, C., eds. The biology of neuropeptide Y. Totowa, NJ: Humana Press; 1993:65-156.
13. 13. Hillenkamp, F.; Karas, M. Mass spectrometry of peptides and proteins by matrix-assisted ultraviolet laser desorption/ionization. In: McCloskey, J., ed. Methods in enzymology, vol. 193. Mass spectrometry. San Diego, CA: Academic Press; 1990:280-295.
14. 14. Jiménez, C. R.; van Veelen, P. A.; Li, K. W.; et al. Neuropeptide expression and processing as revealed by direct matrix-assisted laser desorption ionization mass spectrometry of single neurons. J. Neurochem. 62:404-407; 1994.
15. 15. Juhasz, P.; Costello, C. E.; Biemann, K. Matrix-assisted laser desorption ionization mass spectrometry with 2-(4-hydroxyphenylazo) benzoic acid matrix. J. Am. Soc. Mass Spectrom. 4:399-409; 1993.
16. 16. Karas, M.; Bachmann, D.; Bahr, U.; Hillenkamp, F. Matrix-assisted ultraviolet laser desorption of nonvolatile compounds. Int. J. Mass Spectrom. Ion Processes 78:53-68; 1987.
17. 17. Liu, D.; Dass, C.; Wood, G.; Desiderio, D. M. Opiod and tachykinin peptides and their precursors and precursor-processing enzymes in human CSF. J. Chromatogr. 500:395; 1990.
18. 18. McDonald, J. K.; Koenig, J. I. Neuropeptide Y actions on reproductive and endocrine functions. In: Colmers, W. F.; Wahlestedt, C., eds. The biology of neuropeptide Y. Totowa, NJ: Humana Press; 1993:419-456.
19. 19. Minth, C. D.; Bloom, S. R.; Polak, J. M.; Dixon, J. E. Cloning, characterization, and DNA sequence of human cDNA encoding neuropeptide tyrosine. Proc. Natl. Acad. Sci. USA 81:4577-4581; 1984.
20. 20. Stanley, B. G. Neuropeptide Y in multiple hypothalamic sites controls eating, behavior, endocrine and autonomic systems for body energy balance. In: Colmers, W. F.; Wahlestedt, C., eds. The biology of neuropeptide Y. Totowa, NJ: Humana Press; 1993:457-510.
21. 21. Strupat, K.; Karas, M.; Hillenkamp, F. 2.5-Dihydroxybenzoic acid: A new matrix for laser desorption-ionization mass spectrometry. Int. J. Mass Spectrom. Ion Processes 111:89-102; 1991.
22. 22. Tanaka, K.; Waki, H.; Ido, Y.; Akita, S. Protein and polymer analyses up to m/z 100,000 by laser ionization time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 3:151-153; 1989.
23. 23. Tatemoto, K.; Carlquist, M.; Mutt, V. Neuropeptide Y - a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296:659-660; 1982.
24. 24. Widerlöv, E.; Lindström, L. H.; Wahlestedt, C.; Ekman, R. Neuropeptide Y (NPY) and peptide YY (PYY) as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively. J. Psychiatr. Res. 22:69-79; 1988.
25. 25. Widerlöv, E.; Heilig, M.; Ekman, R.; Wahlestedt, C. Neuropeptide Y - possible involvement in depression and anxiety. In Mutt, V., et al., eds. Neuropeptide Y. New York: Raven Press; 1989:331-342.